Average Co-Inventor Count = 5.59
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (44 from 665 patents)
2. Incyte Holdings Corporation (15 from 147 patents)
44 patents:
1. 12084449 - Imidazotriazines and imidazopyrimidines as kinase inhibitors
2. 11840534 - Substituted tricyclic compounds as FGFR inhibitors
3. 11261191 - Imidazotriaines and imidazopyrimidines as kinase inhibitors
4. 11053246 - Substituted tricyclic compounds as FGFR inhibitors
5. 10968221 - Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
6. 10813930 - Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
7. 10738052 - Imidazotriaines and imidazopyrimidines as kinase inhibitors
8. 10640503 - Imidazopyridines and imidazopyrazines as LSD1 inhibitors
9. 10556908 - Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
10. 10213427 - Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
11. 10138249 - Triazolopyridines and triazolopyrazines as LSD1 inhibitors
12. 10131667 - Substituted tricyclic compounds as FGFR inhibitors
13. 10125133 - Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
14. 10112950 - Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
15. 10047086 - Imidazopyridines and imidazopyrazines as LSD1 inhibitors